SEARCH RESULTS FOR: (*bingo lotto 90 number玩法➝(發財88 >www.games141.co)➝台27線,wr5fm*)(541156 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G29(2.0-3.0mm,30c.c.)
In Commercial Distribution
- 04719875722318 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G28(2.0-3.0mm,20c.c.)
In Commercial Distribution
- 04719875722301 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G27(2.0-3.0mm,15c.c.)
In Commercial Distribution
- 04719875722295 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G26(1.0-2.0mm,30c.c.)
In Commercial Distribution
- 04719875722288 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G25(1.0-2.0mm,20c.c.)
In Commercial Distribution
- 04719875722271 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G24(1.0-2.0mm,15c.c.)
In Commercial Distribution
- 04719875722264 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G23(0.5-1.0mm,2c.c.)
In Commercial Distribution
- 04719875722257 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G22(1.0-2.0mm,2c.c.)
In Commercial Distribution
- 04719875722240 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G21(2.0-3.0mm,2c.c.)
In Commercial Distribution
- 04719875722233 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G20(2.0-3.0mm,0.25g)
In Commercial Distribution
- 04719875722226 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G19 (1.0-2.0mm,1.5g)
In Commercial Distribution
- 04719875722219 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G18(1.0-2.0mm,1.0g)
In Commercial Distribution
- 04719875722202 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G17(1.0-2.0mm,0.5g)
In Commercial Distribution
- 04719875722196 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G16(1.0-2.0mm,0.25g)
In Commercial Distribution
- 04719875722189 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G15(0.5-1.0mm,1g)
In Commercial Distribution
- 04719875722172 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G14(0.5-1.0mm,0.5g)
In Commercial Distribution
- 04719875722165 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G13(0.5-1.0mm,0.25g)
In Commercial Distribution
- 04719875722158 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G12(0.25-0.5mm,1g)
In Commercial Distribution
- 04719875722141 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G11(0.25-0.5mm,0.5g)
In Commercial Distribution
- 04719875722134 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G10(0.25-0.5mm,0.25g)
In Commercial Distribution
- 04719875722127 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G09(0.5-1.0mm,10c.c.)
In Commercial Distribution
- 04719875722110 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G08(0.5-1.0mm,7c.c.)
In Commercial Distribution
- 04719875722103 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G07(1.0-2.0mm,10c.c.)
In Commercial Distribution
- 04719875722097 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G06(1.0-2.0mm,7c.c.)
In Commercial Distribution
- 04719875722080 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G05(2.0-3.0mm,10c.c.)
In Commercial Distribution
- 04719875722073 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-G03(0.5-1.0mm,5c.c.)
In Commercial Distribution
- 04719875722059 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-B04(5x5x10mm,7c.c.)
In Commercial Distribution
- 04719875721946 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-B03(5x5x10mm,5c.c.)
In Commercial Distribution
- 04719875721939 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-B02(5x5x10mm,2c.c.)
In Commercial Distribution
- 04719875721922 ()
- Synthetic bone graft
Bicera® Resorbable Bone Substitute is a bioceramic medical device that its composition of crystalline phase contains 60%
hydroxyapatite (HAP) and 40% beta-tricalcium (ß-TCP).
Bicera® Resorbable Bone Substitute is intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure. Bicera® Resorbable Bone Substitute is indicated for use in the treatment of surgically created osseous defects or osseous defects resulting from traumatic injury to the bone. Bicera® Resorbable Bone Substitute is intended to be packed into bony voids or gaps of the skeletal system (i.e., extremities, posterolateral spine and pelvis) as a bone void filler. This product provides a bone void filler that resorbs and is replaced by bone during the healing process.
WILTROM CO., LTD.
BC-B01(5x5x20mm,2c.c.)
In Commercial Distribution
- 04719875721915 ()
- Synthetic bone graft